Contact Us

HOTEL NEWS

DFRobot Drives Industrial Innovation with Rapid Prototyping Solutions at Embedded World 2025

Mar 12, 2025

SHANGHAI,March 12,2025-- DFRobot,a global leader in open-source hardware and embedded development tools,warmly invites engineers and innovators to visit their booth (Hall 1-517) at Embedded World 2025

AIM Vaccine's Serum-Free Iterative Rabies Vaccine Has Received Production License and Will Submit for Market Registration

Mar 12, 2025

Launch of Major Product Expected to Significantly Drive Performance Growth HONG KONG,March 12,2025-- AIM Vaccine Co.,Ltd. (06660.HK),a leading PRC vaccine company,published an announcement on March 12

XJTLU-ISCA partnership opens accelerated pathway to accountancy careers in Singapore

Mar 11, 2025

SUZHOU,China,March 10,2025--Students at Xi\'an Jiaotong-Liverpool Universitycan now fast-track towards a career in accountancyin Singapore thanks to a partnership between XJTLU\'s International Busine

Webull Singapore launches trading competition for Singapore traders

Mar 11, 2025

SINGAPORE,March 10,2025--Webull Securities (Singapore)Pte Ltd ("Webull Singapore"),a subsidiary of Webull Corporation,a leading digital investment platform,has officially launched a trading

Doer Biologics Completes Enrollment of the Phase 2 Clinical Study of DR10624 for Treatment of Severe Hypertriglyceridemia

Mar 11, 2025

HANGZHOU,China,March 10,2025-- Zhejiang Doer Biologics Co.,Ltd. ("Doer Bio"),a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and canc

RiboX Therapeutics Announces First Patient Dosed in Phase I/IIa Clinical Trial of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation

Mar 11, 2025

PRINCETON,N.J.,March 10,2025--RiboX Therapeutics Ltd. (RiboX),a pioneering biopharmaceutical company,focused on discovering and developing fully engineered circular RNA therapeutics,todayannouncedthat

1 ... 54 55 56 57 58 59 60 ... 344